Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank56
3Y CAGR-37.1%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-37.1%/yr
Annual compound
Percentile
P56
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.69 | -64.4% |
| 2024 | 4.74 | -92.1% |
| 2023 | 60.08 | +786.7% |
| 2022 | 6.78 | -70.5% |
| 2021 | 22.95 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |